UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Design of Selective, ATP-Competitive Inhibitors of Akt

Journal of medicinal chemistry, 2010-06, Vol.53 (12), p.4615-4622

2010

Volltextzugriff (PDF)

Synthesis and structure based optimization of novel Akt inhibitors

Bioorganic & medicinal chemistry, 2008-06, Vol.18 (11), p.3359-3363

2008

Volltextzugriff (PDF)

The Hedgehog signaling pathway as a target for anticancer drug discovery

Current topics in medicinal chemistry, 2005-01, Vol.5 (2), p.147-157

2005

Volltextzugriff (PDF)

595 Inhibition of integrin αvβ8 in combination with low dose radiation induces antitumor effect in advanced immune checkpoint blockade refractory tumor model

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A625-A625

2021

Volltextzugriff (PDF)

The discovery of highly selective erbB2 (Her2) inhibitors for the treatment of cancer

Bioorganic & medicinal chemistry letters, 2007-06, Vol.17 (11), p.3081-3086

2007

Volltextzugriff (PDF)

Sa1761 PREDICTIVE TRANSLATIONAL BLOOD BIOMARKER DYNAMICS OF SMALL MOLECULE α4β7 INHIBITION IN NONHUMAN PRIMATE

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-420-S-421

2023

Volltextzugriff (PDF)

The Design, Computer Modeling, Solution Structure, and Biological Evaluation of Synthetic Analogs of Bryostatin 1

Proceedings of the National Academy of Sciences - PNAS, 1998-06, Vol.95 (12), p.6624-6629

1998

Volltextzugriff (PDF)

The development of a gut-specific immune response to an oral antigen is dependent on α4β7 mediated lymphocyte trafficking

The Journal of immunology (1950), 2022-05, Vol.208 (1_Supplement), p.105-105.06

2022

Volltextzugriff (PDF)

Su1121: PHARMACOLOGIC INHIBITION OF INTEGRIN α4β7 BY SMALL MOLECULE INHIBITOR ARRESTS B LYMPHOCYTE TRAFFICKING TO MURINE GUT-ASSOCIATED LYMPHOID TISSUES

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-510-S-511

2022

Volltextzugriff (PDF)

Abstract 1559: Inhibition of integrin αvβ8 enhances immune checkpoint induced anti-tumor immunity by acting across immunologic synapse in syngeneic models of breast cancer

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1559-1559

2021

Volltextzugriff (PDF)

Modeling relationship of pharmacokinetics, in vitro potency, and α4β7 receptor occupancy with intestinal cell trafficking in a gut-homing mouse model of IBD with MORF-057

The Journal of immunology (1950), 2021-05, Vol.206 (1_Supplement), p.11-11.15

2021

Volltextzugriff (PDF)

AlphaVbeta6 inhibitor stabilizing the bent closed integrin conformation is effective in primary sclerosis cholangitis mouse model

Journal of hepatology, 2020-08, Vol.73, p.S522-S523

2020

Volltextzugriff (PDF)

FRI248 - AlphaVbeta6 inhibitor stabilizing the bent closed integrin conformation is effective in primary sclerosis cholangitis mouse model

Journal of hepatology, 2020-08, Vol.73, p.S522-S523

2020

Volltextzugriff (PDF)

Integrin alphaVbeta1 inhibition ameliorates liver fibrosis in mice

Journal of hepatology, 2020-08, Vol.73, p.S522

2020

Volltextzugriff (PDF)

FRI247 - Integrin alphaVbeta1 inhibition ameliorates liver fibrosis in mice

Journal of hepatology, 2020-08, Vol.73, p.S522-S522

2020

Volltextzugriff (PDF)

Tu1283 PRECLINICAL CHARACTERIZATION OF AN ORAL SMALL MOLECULE INHIBITOR TARGETING THE INTEGRIN α4β7 FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES (IBD)

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-1043-S-1043

2020

Volltextzugriff (PDF)

Inhibitors of Akt Activity

Expert opinion on therapeutic patents, Vol.17 (5), p.577-581

Lippa, Blaise

Volltextzugriff (PDF)

Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrB

Bioorganic & medicinal chemistry letters, 2016-02, Vol.26 (4), p.1314-1318

2016

Volltextzugriff (PDF)

Biarylsulfonamide CCR9 inhibitors for inflammatory bowel disease

Bioorganic & medicinal chemistry letters, 2015-09, Vol.25 (17), p.3661-3664

2015

Volltextzugriff (PDF)

Inhibitors of Akt Activity: SmithKline Beecham Corporation: WO2006113837

Expert opinion on therapeutic patents, 2007-05, Vol.17 (5), p.577-581

Lippa, Blaise

2007

Volltextzugriff (PDF)

Discovery of Azaindole Ureas as a Novel Class of Bacterial Gyrase B Inhibitors

Journal of medicinal chemistry, 2015-11, Vol.58 (21), p.8503-8512

2015

Volltextzugriff (PDF)

In-silico guided discovery of novel CCR9 antagonists

Journal of computer-aided molecular design, 2018-04, Vol.32 (4), p.573-582

2018

Volltextzugriff (PDF)

Structure-based discovery of LpxC inhibitors

Bioorganic & medicinal chemistry letters, 2017-04, Vol.27 (8), p.1670-1680

2017

Volltextzugriff (PDF)

Discovery of Pyrazolopyridones as a Novel Class of Gyrase B Inhibitors Using Structure Guided Design

ACS medicinal chemistry letters, 2016-04, Vol.7 (4), p.374-378

2016

Volltextzugriff (PDF)

Discovery of indole inhibitors of chemokine receptor 9 (CCR9)

Bioorganic & medicinal chemistry letters, 2016-07, Vol.26 (14), p.3322-3325

2016

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(42)

Publikationsform

Sprache

Englisch
(45)
Japanisch
(4)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Design of Selective, ATP-Competitive Inhibitors of Akt

Synthesis and structure based optimization of novel Akt inhibitors

The Hedgehog signaling pathway as a target for anticancer drug discovery

595 Inhibition of integrin αvβ8 in combination with low dose radiation induces antitumor effect in advanced immune checkpoint blockade refractory tumor model

The discovery of highly selective erbB2 (Her2) inhibitors for the treatment of cancer

Sa1761 PREDICTIVE TRANSLATIONAL BLOOD BIOMARKER DYNAMICS OF SMALL MOLECULE α4β7 INHIBITION IN NONHUMAN PRIMATE

The Design, Computer Modeling, Solution Structure, and Biological Evaluation of Synthetic Analogs of Bryostatin 1

The development of a gut-specific immune response to an oral antigen is dependent on α4β7 mediated lymphocyte trafficking

Su1121: PHARMACOLOGIC INHIBITION OF INTEGRIN α4β7 BY SMALL MOLECULE INHIBITOR ARRESTS B LYMPHOCYTE TRAFFICKING TO MURINE GUT-ASSOCIATED LYMPHOID TISSUES

Abstract 1559: Inhibition of integrin αvβ8 enhances immune checkpoint induced anti-tumor immunity by acting across immunologic synapse in syngeneic models of breast cancer

Modeling relationship of pharmacokinetics, in vitro potency, and α4β7 receptor occupancy with intestinal cell trafficking in a gut-homing mouse model of IBD with MORF-057

AlphaVbeta6 inhibitor stabilizing the bent closed integrin conformation is effective in primary sclerosis cholangitis mouse model

FRI248 - AlphaVbeta6 inhibitor stabilizing the bent closed integrin conformation is effective in primary sclerosis cholangitis mouse model

Integrin alphaVbeta1 inhibition ameliorates liver fibrosis in mice

FRI247 - Integrin alphaVbeta1 inhibition ameliorates liver fibrosis in mice

Tu1283 PRECLINICAL CHARACTERIZATION OF AN ORAL SMALL MOLECULE INHIBITOR TARGETING THE INTEGRIN α4β7 FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES (IBD)

Inhibitors of Akt Activity

Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrB

Biarylsulfonamide CCR9 inhibitors for inflammatory bowel disease

Inhibitors of Akt Activity: SmithKline Beecham Corporation: WO2006113837

Discovery of Azaindole Ureas as a Novel Class of Bacterial Gyrase B Inhibitors

In-silico guided discovery of novel CCR9 antagonists

Structure-based discovery of LpxC inhibitors

Discovery of Pyrazolopyridones as a Novel Class of Gyrase B Inhibitors Using Structure Guided Design

Discovery of indole inhibitors of chemokine receptor 9 (CCR9)

Suchergebnisse filtern